11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with atenolol in 1 studies
| Studies (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Trials (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Recent Studies (post-2010) (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Studies (atenolol) | Trials (atenolol) | Recent Studies (post-2010) (atenolol) |
|---|---|---|---|---|---|
| 304 | 27 | 103 | 58 | 1 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audette, CA; Burstein, S | 1 |
1 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and atenolol
| Article | Year |
|---|---|
Inhibition of leukocyte adhesion by the in vivo and in vitro administration of cannabinoids.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cell Adhesion; Cells, Cultured; Dronabinol; Ethanol; Hydroxyeicosatetraenoic Acids; Indomethacin; Isomerism; Leukocytes; Male; Masoprocol; Mice; Mice, Inbred Strains; Prostaglandins; Reference Values | 1990 |